Pfizer halts heart failure trial early for benefit
by on Jun.17, 2010, under Uncategorized
Pfizer Inc said on Thursday it is halting recruitment of patients into a heart failure clinical study involving its drug Inspra because the study reached its main efficacy goal early.
View full post on Yahoo! Health News
